Celldex Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $17M | 422k | 39.66 |
| 2023-09-30 | $13M | 468k | 27.52 |
| 2023-06-30 | $16M | 479k | 33.93 |
| 2023-03-31 | $26M | 714k | 35.98 |
| 2022-12-31 | $37M | 833k | 44.57 |
| 2022-03-31 | $36M | 1.1M | 34.06 |
| 2021-12-31 | $35M | 916k | 38.64 |
| 2021-09-30 | $47M | 878k | 53.99 |
| 2021-06-30 | $13M | 389k | 33.44 |
| 2021-03-31 | $6.8M | 332k | 20.60 |
| 2020-12-31 | $5.1M | 293k | 17.52 |